BNP Paribas Financial Markets
ARMP icon

BNP Paribas Financial Markets’s Armata Pharmaceuticals ARMP Stock Holding History

BNP Paribas Financial Markets’s Portfolio ARMP Stock Details ARMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.7K Buy
+3,038
New +$27.9K ﹤0.01% 5261
2026
Q1 		– Sell
-710
Closed -$4.46K – 5826
2025
Q4 		$4.46K Buy
+710
New +$3.89K ﹤0.01% 5273

Other funds holding ARMP

MAM
Madison Asset Management Madison, Wisconsin $8.39B AUM 16.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Edgewood Management
Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return

BNP Paribas Financial Markets's ARMP Position: Q2 2026 in Review

BNP Paribas Financial Markets opened a new position in Armata Pharmaceuticals (ARMP) in Q2 2026: 3,038 shares worth $19.7K. The stake represents ﹤0.01% of the portfolio and ranks #5261 among its holdings. This is a return to the name: BNP Paribas Financial Markets previously reported a position in ARMP as recently as Q4 2025.

BNP Paribas Financial Markets first reported a position in ARMP in Q4 2025 and has held it in 2 quarters since. 53 funds tracked by Wall St. Rank hold ARMP as of Q2 2026.

  • BNP Paribas Financial Markets held 3,038 shares of Armata Pharmaceuticals worth $19.7K as of Q2 2026.
  • Armata Pharmaceuticals was a new BNP Paribas Financial Markets position in Q2 2026.
  • Armata Pharmaceuticals made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #5261 holding.
  • BNP Paribas Financial Markets first reported a position in Armata Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • 53 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.